Comparison between conventional and extended Letrozole regimens for ovulation induction in PCOS infertile women.

Comparative study of conventional vs extended Letrozole therapy for ovulation induction in infertile females with PCOS. - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/113141

Enrollment

120

Registered

2026-06-29

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: - Health Condition 3: -

Interventions

Intervention1: letrozole: letrozole for ovulation induction will be given for 5 days Control Intervention1: letrozole: letrozole for ovulation induction will be given for 7 days

Eligibility

Inclusion criteria

Inclusion criteria: Infertile PCOS females

Exclusion criteria

Exclusion criteria: other causes of infertility like tubal or male factor infertility

Design outcomes

Primary

Measure	Time frame
1.To see ovulation rates in infertile PCOS females with conventional letrozole treatment- 2. To see ovulation rates in infertile PCOS females with extended Letrozole treatment.Timepoint: 1.After 5 days with conventional letrozole treatment 2. After 7 days with extended Letrozole treatment.	—

Secondary

Measure	Time frame
1.To evaluate follicular development 2.Clinical & biochemical pregnancy ratesTimepoint: 1. Follicular development started after 5 days with conventional & 7 days with extended letrozole Pregnancy rate after 14 days of IUI	—

Countries

India

Contacts

Public ContactDr.Vandana Solanki

Queen Mary Hospital , KGMU

rakhshishamim001@gmail.com9305347770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026